{"id":"https://openalex.org/W4388082439","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0182","title":"182 Peripheral immunological features as predictors of breast cancer chemoimmunotherapy response","display_name":"182 Peripheral immunological features as predictors of breast cancer chemoimmunotherapy response","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388082439","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0182"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0182","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0182","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0182","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A206.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A206.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018914026","display_name":"Xiaopeng Sun","orcid":"https://orcid.org/0009-0009-5219-8964","observed_orcids":["https://orcid.org/0009-0009-5219-8964"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaopeng Sun","raw_affiliation_strings":["Vanderbilt University, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074731809","display_name":"Brandie C. Taylor","orcid":"https://orcid.org/0000-0002-4862-4678","observed_orcids":["https://orcid.org/0000-0002-4862-4678"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandie C Taylor","raw_affiliation_strings":["Vanderbilt University, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060074645","display_name":"Margaret L. Axelrod","orcid":"https://orcid.org/0000-0003-4713-8798","observed_orcids":["https://orcid.org/0000-0003-4713-8798"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret Axelrod","raw_affiliation_strings":["Vanderbilt University, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023245303","display_name":"Lamorna Brown Swigart","orcid":"https://orcid.org/0000-0003-2076-5177","observed_orcids":["https://orcid.org/0000-0003-2076-5177"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lamorna Swigart","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014135109","display_name":"Laura van \u2018t Veer","orcid":"https://orcid.org/0000-0002-9838-8298","observed_orcids":["https://orcid.org/0000-0002-9838-8298"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura van \u2018t Veer","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076178845","display_name":"Gillian L. Hirst","orcid":"https://orcid.org/0000-0002-4502-0035","observed_orcids":["https://orcid.org/0000-0002-4502-0035"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gillian Hirst","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089113899","display_name":"Justin Micah Balko","orcid":"https://orcid.org/0000-0002-4263-5974","observed_orcids":["https://orcid.org/0000-0002-4263-5974"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin M Balko","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A206","last_page":"A206"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.2671000063419342,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8700000047683716},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.9480000138282776},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.8970000147819519},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9049999713897705},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9129999876022339},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.925000011920929},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.7979999780654907},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.7630000114440918},{"id":"https://openalex.org/keywords/blood-based-biomarkers","display_name":"blood-based biomarkers","score":0.8100000023841858},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.890999972820282},{"id":"https://openalex.org/keywords/naive-cd8-t-cells","display_name":"naive CD8+ T cells","score":0.8569999933242798},{"id":"https://openalex.org/keywords/interferon-response","display_name":"interferon response","score":0.7089999914169312}],"concepts":[{"id":"https://openalex.org/C2780790343","wikidata":"https://www.wikidata.org/wiki/Q5090610","display_name":"Chemoimmunotherapy","level":4,"score":0.9178944826126099},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.781753659248352},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.696537971496582},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6313199996948242},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5914833545684814},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4730733335018158},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4707052409648895},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.46123456954956055},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.41005662083625793},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3745304346084595},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3143491744995117}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0182","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0182","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0182","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A206.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:d6ed9f370908448ba953cb952c546b2d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d6ed9f370908448ba953cb952c546b2d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0182","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0182","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0182","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A206.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388082439.pdf","grobid_xml":"https://content.openalex.org/works/W4388082439.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4412095090","https://openalex.org/W7155182061","https://openalex.org/W7129549823","https://openalex.org/W7130714453","https://openalex.org/W4412011839","https://openalex.org/W4221058292","https://openalex.org/W7161751128","https://openalex.org/W4396607282","https://openalex.org/W2983751044","https://openalex.org/W7129370241"],"abstract_inverted_index":{"Background":[0],"Breast":[1],"cancer":[2,43,126,143,251,307],"remains":[3],"a":[4,82,93,268,295,344,352],"significant":[5,207,296],"global":[6],"health":[7],"challenge,":[8],"and":[9,58,106,144,155,175,215,265,322,327,375,400],"the":[10,36,47,73,149,240,316,323,384,397],"development":[11],"of":[12,49,75,209,234,256,271,289,298,303,318,325],"effective":[13],"treatments":[14],"is":[15],"urgently":[16],"needed.":[17],"Recent":[18],"phase":[19],"III":[20],"clinical":[21,103],"studies":[22],"have":[23],"demonstrated":[24],"that":[25,120,340],"combining":[26],"neoadjuvant":[27,87],"chemotherapy":[28],"with":[29,186,212,248,357],"immune":[30,196,213,260,299,319,346],"checkpoint":[31],"inhibitors":[32],"(ICI)":[33],"can":[34,51],"improve":[35,102],"response":[37,96,123,214,217,300,310],"rate":[38],"in":[39,124,148,239,276,333,367,396],"early-stage":[40],"triple-negative":[41],"breast":[42,125,142,250,306],"(TNBC)":[44],"patients.":[45,127],"However,":[46],"addition":[48,74],"ICI":[50,76,358],"introduce":[52],"unnecessary":[53],"(and":[54],"potentially":[55],"permanent)":[56],"toxicity":[57],"financial":[59],"burden":[60],"to":[61,68,77,115,181,192,204,219,259,263,294,359,382],"non-responders.":[62],"Currently,":[63],"no":[64],"biomarkers":[65,91,374],"are":[66],"available":[67],"identify":[69,116,182],"individuals":[70],"who":[71,202],"require":[72],"achieve":[78],"pathologic":[79],"complete":[80],"response,":[81,347],"positive":[83],"prognostic":[84],"marker":[85],"after":[86,243],"therapy.":[88,228],"Developing":[89],"blood-based":[90],"representing":[92],"dynamic":[94],"immunologic":[95],"could":[97],"help":[98],"select":[99],"appropriate":[100],"patients,":[101,391],"trial":[104],"success,":[105],"expand":[107],"treatment":[108,170,304,342],"applicability.":[109],"In":[110],"this":[111],"study,":[112],"we":[113,338,380],"aim":[114],"peripheral":[117,194,241,278],"immunological":[118],"features":[119],"predict":[121],"chemoimmunotherapy":[122,187,205,246,335,377],"Methods":[128],"Longitudinal":[129],"buffy":[130,385],"coat":[131,386],"blood":[132,162,195,242],"samples":[133,163,387],"were":[134,164],"collected":[135],"from":[136,388],"40":[137],"patients":[138,201,285],"(20":[139],"hormone":[140],"receptor-positive":[141],"20":[145],"TNBC)":[146],"enrolled":[147],"I-SPY2":[150,398],"trial\u2019s":[151],"paclitaxel":[152,158],"(control)":[153],"arm":[154],"pembrolizumab":[156],"+":[157],"(pembro4)":[159],"arm.":[160],"The":[161],"obtained":[165],"at":[166,221],"pretherapy,":[167],"during":[168,227],"early":[169,328],"(paclitaxel":[171],"\u00b1":[172],"pembrolizumab),":[173],"pre-anthracycline,":[174],"pre-surgery.":[176],"We":[177],"performed":[178],"RNA":[179],"sequencing":[180],"transcriptomic":[183],"signatures":[184,224,321],"associated":[185,211],"response.":[188,336],"CibersortX":[189],"was":[190],"applied":[191],"estimated":[193],"cell":[197],"composition.":[198],"Results":[199],"TNBC":[200],"responded":[203],"exhibited":[206],"upregulation":[208,297],"genes":[210,257],"interferon":[216],"compared":[218,262],"non-responders":[220],"baseline.":[222],"These":[223],"remained":[225],"upregulated":[226],"Additionally,":[229,337],"responders":[230,247],"experienced":[231],"an":[232],"expansion":[233],"early-activated":[235],"CD8":[236,273,330],"T":[237,274,331],"cells":[238,275,332],"chemoimmunotherapy.":[244],"Conversely,":[245],"HR+":[249],"generally":[252],"showed":[253],"lower":[254],"expression":[255],"related":[258],"activation":[261,320],"non-responders,":[264],"they":[266],"maintained":[267],"substantial":[269],"proportion":[270],"na\u00efve":[272,326],"their":[277,281],"blood.":[279],"After":[280],"initial":[282],"treatment,":[283],"all":[284,393],"received":[286],"four":[287,394],"cycles":[288],"anthracycline":[290,341],"therapy,":[291],"which":[292],"led":[293],"genes,":[301],"regardless":[302],"arms,":[305],"subtypes,":[308],"or":[309,354],"status.":[311],"Conclusions":[312],"Our":[313],"findings":[314],"highlight":[315],"significance":[317],"abundance":[324],"activated":[329],"predicting":[334],"observed":[339],"elicits":[343],"potent":[345],"suggesting":[348],"its":[349],"potential":[350],"as":[351],"pre-treatment":[353],"combination":[355],"therapy":[356],"enhance":[360],"anti-tumor":[361],"immunity":[362],"(similar":[363],"observation":[364],"also":[365],"reported":[366],"TONIC":[368],"trial).":[369],"To":[370],"further":[371],"validate":[372],"these":[373],"explore":[376],"resistance":[378],"mechanism,":[379],"plan":[381],"sequence":[383],"over":[389],"150":[390],"encompassing":[392],"timepoints,":[395],"control":[399],"Pembro4":[401],"arms.":[402]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}